This meta-analysis evaluates vitamin D effects on blood lipids in metabolic syndrome, suggesting potential benefits for triglycerides and HDL cholesterol.
Key Points
This meta-analysis aims to evaluate the impact of vitamin D supplementation on blood lipid levels in patients with metabolic syndrome.
Conducted a search for randomized controlled trials from 1948 to February 2026.
Included trials where vitamin D was administered to individuals with metabolic syndrome.
Performed a meta-analysis on data from selected studies.
Vitamin D supplementation significantly reduced triglyceride levels by an average of 12.64 mg/dL.
No significant changes in total cholesterol or LDL cholesterol levels were found.
Vitamin D supplementation increased HDL cholesterol levels, especially with daily regimens, by an average of 1.77 mg/dL.